Nephrogenic systemic fibrosis: risk factors and incidence estimation.
暂无分享,去创建一个
A. Djamali | E. Sadowski | A. Wentland | M. Chan | Elizabeth A Sadowski | Arjang Djamali | L. Bennett | Andrea L Garrett | Robert W. Garrett | Andrew L Wentland | Micah R Chan | Lindsey K Bennett | Robert W Garrett
[1] S. Jimenez,et al. Involvement of skeletal muscle in dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy) , 2004, Muscle & nerve.
[2] P. Hals,et al. Biodistribution and toxicity of MR imaging contrast media , 1993, Journal of magnetic resonance imaging : JMRI.
[3] F. Mendoza,et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. , 2006, Seminars in arthritis and rheumatism.
[4] H. Thomsen. European Society of Urogenital Radiology guidelines on contrast media application , 2007, Current opinion in urology.
[5] M. Jarmulowicz,et al. Scleromyxoedema‐like changes in four renal dialysis patients , 2003, The British journal of dermatology.
[6] S. Swaminathan,et al. Nephrogenic fibrosing dermopathy: lessons from the past , 2006, International journal of dermatology.
[7] S. Jimenez,et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. , 2004, Arthritis and rheumatism.
[8] G. Obermoser,et al. Nephrogenic fibrosing dermopathy in two patients with systemic lupus erythematosus , 2004, Lupus.
[9] S. Cowper,et al. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. , 2007, Journal of the American Academy of Dermatology.
[10] S. Cowper. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] M. Zand,et al. Nephrogenic Systemic Fibrosis Among Liver Transplant Recipients: A Single Institution Experience and Topic Update , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[13] D. Cohen,et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). , 2003, Journal of the American Academy of Dermatology.
[14] R. Prayson,et al. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. , 2006, Archives of pathology & laboratory medicine.
[15] H. Thomsen. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide , 2006, European Radiology.
[16] G. Wolf,et al. Leptin and renal disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] J. Zic,et al. Gadolinium deposition in nephrogenic fibrosing dermopathy. , 2007, Journal of the American Academy of Dermatology.
[18] S. Rocklage,et al. Metal ion release from paramagnetic chelates: What is tolerable? , 1991, Magnetic resonance in medicine.
[19] G. Jackson,et al. Gadolinium (III) complex equilibria: The implications for Gd(III) MRI contrast agents , 1990, Magnetic resonance in medicine.
[20] H. Thomsen,et al. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? , 2006, Clinical radiology.
[21] T. Grobner. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] R. Bucala,et al. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy) , 2006, Current opinion in rheumatology.
[23] Lone Skov,et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. , 2006, Journal of the American Society of Nephrology : JASN.
[24] S. Cowper. Nephrogenic fibrosing dermopathy: the first 6 years , 2003, Current opinion in rheumatology.
[25] E. Kanal,et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. , 2007, Radiology.